Allegations surface about Giant Eagle's winning LeNature bid FDA approves Acatvis' generic Duragesic patch Nestle contemplates its options for L'Oreal Caraco announces $14.5 million expansion Icagen and Pfizer complete first closing of R&D deal Colgate appoints key executives Enzon sells quarter share in hepatitis drug Rite Aid holds first managers conference since Brooks/Eckerd acquisition FDA drug approvals are down; excess caution plays a part Adams ranks high on Deloitte list First Previous 1328 1329 1330 1331 1332 Next Last
